Company / EPS (Diluted)
Tango Therapeutics, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.08
FY2025
5-year range
-$1.63 / -$0.94
FY2021-FY2025
Trend
+12.2%
vs FY2024
Sector context
#91 of 204
Health Care
What the data says
At $-1.08, Tango Therapeutics, Inc.'s eps (diluted) ranks #91 of 204 in the Health Care sector. Improved from $-1.23 to $-1.08 over the past 2 years.
Based on SEC 10-K filings.
-1.08 in FY2025.
Improved from $-1.23 to $-1.08 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 204 in Health CareTop 45% of 204This company -$1.08 Sector average -$0.89
▼
-21.9% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 12.2% year-over-year.
- Ranks #91 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.08 | +12.2% |
| FY2024 | -$1.23 | +0.0% |
| FY2023 | -$1.23 | -30.9% |
| FY2022 | -$0.94 | +42.3% |
| FY2021 | -$1.63 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026